Carr Douglas 4

What Happened

• Carr Douglas, SVP Finance & Operations at Century Therapeutics (IPSC), disposed of 264 shares on May 4, 2026.
• The shares were sold at $2.34 each for total proceeds of $618. The filing shows the sale was to cover tax withholding related to the vesting of restricted stock units (RSUs) and was automatic, not at the reporting person's discretion.
• This was a sale (routine tax-withholding transaction), not a purchase—such transactions are typically administrative rather than a signal of insider sentiment.

Key Details

• Transaction date: 2026-05-04; sale price: $2.34 per share; total proceeds: $618.
• Transaction type/code: Sale (S); described as open market or private sale.
• Footnote: The sale was automatic to satisfy tax withholding obligations on vested RSUs (footnote F1).
• Shares owned after the transaction: not specified in the Form 4 provided.
• Filing date: 2026-05-06 (appears to be filed timely within the Form 4 reporting window).
• No 10b5-1 trading plan or other plan was disclosed in the summary information provided.

Context

• Sales to cover tax withholding on vested RSUs are routine administrative actions and generally don't reflect a change in an insider's view of the company.
• The dollar amount here ($618) is minimal; retail investors should weigh larger, discretionary insider purchases/sales more heavily when assessing insider sentiment.